• <em>Jiao's</em> style scalp acupuncture combined with physiotherapy for autosomal recessive spastic ataxia of Charlevoix-Saguenay type: A case report
• 6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway
• A case of chorea-acanthocytosis with significant improvement of symptoms at one year with deep brain stimulation: case report and literature review
• A case of hemichorea/hemiballismus in a patient with Alzheimer's disease and history of Sydenham's chorea: the return of an old acquaintance?
• A Case of Non-ketotic Hyperglycemic Hemichorea and Fahr Syndrome
• A Man With Progressive Chorea and Abnormal Trunk Movements
• Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming
• Analysis of Brain, Blood, and Testis Phenotypes Lacking the <em>Vps13a</em> Gene in C57BL/6N Mice
• Analysis of clinical characteristics and variant of NKX2-1 gene in a Chinese boy with Brain-Lung-Thyroid syndrome
• Antiphospholipid syndrome in children
• Assessment of the diagnostic utility of the electroencephalogram in pediatric emergencies
• Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease
• Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease
• Bilateral Chorea-Ballism Associated With Non-ketotic Hyperglycemia: A Case Report
• Brain cholesterol therapy for Huntington's disease - Does it make sense?
• Case report: Misdiagnosed orolingual dyskinesia as a consequence of seizures in a chorea-acanthocytosis patient with a novel VPS13A variation from a family with consanguineous marriage
• Central nervous system manifestations in rheumatic diseases
• Chorea - Is Diabetes Mellitus the Cause?
• Chorea as a Post-COVID-19 Complication
• Clinical profile of paediatric acute rheumatic fever and rheumatic heart disease in Western Australia: 1987 to 2020
• Cognitive reserve involves decision making and is associated with left parietal and hippocampal hypertrophy in neurodegeneration
• Concurrent Amyotrophic Lateral Sclerosis and Huntington's Disease: A Case Report
• Crossed-reflex in antiphospholipid chorea
• Dalzanemdor (SAGE-718), a novel, investigational N-methyl-D-aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose-finding studies in healthy participants and an open-label study in participant
• Dentatorubral-pallidoluysian atrophy: a rare cause of epilepsy, ataxia and chorea
• Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa
• Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington's Disease
• Differential diagnosis of Huntington's disease- neurological aspects of NKX2-1-related disorders
• Disruption of the mitochondrial network in a mouse model of Huntington's disease visualized by in-tissue multiscale 3D electron microscopy
• Dynamic undirected graphical models for time-varying clinical symptom and neuroimaging networks
• Effect of 3-nitropropionic acid on sirtuin gene expression in Sirt3 deficient mice
• Effect of Capsaicin on 3-NP-Induced Neurotoxicity: A Pre-Clinical Study
• Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model
• Estimation of Gait Parameters in Huntington's Disease Using Wearable Sensors in the Clinic and Free-living Conditions
• Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington's disease cases
• Excessive STAU1 condensate drives mTOR translation and autophagy dysfunction in neurodegeneration
• Exploring the Genetic Landscape of Chorea in Infancy and Early Childhood: Implications for Diagnosis and Treatment
• Gastrodin Improves the Activity of the Ubiquitin-Proteasome System and the Autophagy-Lysosome Pathway to Degrade Mutant Huntingtin
• Global huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas
• Gray matter alterations in Huntington's disease: A meta-analysis of VBM neuroimaging studies
• Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease
• Huntingtin contains an ubiquitin-binding domain and regulates lysosomal targeting of mitochondrial and RNA-binding proteins
• Huntingtin is an RNA binding protein and participates in <em>NEAT1</em>-mediated paraspeckles
• Huntington's disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids
• Huntington's Disease: Latest Frontiers in Therapeutics
• Hyperglycemic Chorea
• Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach
• Influence of dietary patterns in the pathophysiology of Huntington's Disease: A literature review
• Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders
• Isolated Toe Tremor Associated with Antiphospholipid Syndrome
• Late-onset Chorea with a Rare but Identifiable Cause
• Level of knowledge and perceived challenges associated with learning movement disorders topics: a critical review of final-year medical students at a Nigerian private university
• Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament light
• Microglial proliferation and astrocytic protein alterations in the human Huntington's disease cortex
• Mitochondrial targeted antioxidants as potential therapy for huntington's disease
• Modifiable factors associated with Huntington's disease progression in presymptomatic participants
• Morvan Fibrillary Chorea Associated with Monoclonal B Cell Lymphocytosis
• Motor skill learning modulates striatal extracellular vesicles' content in a mouse model of Huntington's disease
• mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs <em>In Vivo</em>
• Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state
• Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure
• Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo¹H-MRS studies
• Neuroprotection by ADAM10 inhibition requires TrkB signaling in the Huntington's disease hippocampus
• Neurosurgical therapy possibilities in treatment of Huntington disease: An update
• Nuclear poly-glutamine aggregates rupture the nuclear envelope and hinder its repair
• Oropharyngeal Dysphagia Phenotypes Across Huntington's Disease Stages: Endoscopic Findings and Tongue Pressure Analysis
• Outcomes of Percutaneous Endoscopic Gastrostomy in Huntington's Disease at a Tertiary Center
• Paraneoplastic neurological syndromes of small cell lung cancer
• Paroxysmal movement disorders
• Peripheral sequestration of huntingtin delays neuronal death and depends on N-terminal ubiquitination
• Person-centred integrated care for people living with Parkinson's, Huntington's and Multiple Sclerosis: A systematic review
• Phenomenological patterns and aetiological spectrum in patients visiting a tertiary care Movement disorders service in India: An observational study
• Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
• Preserved VPS13A distribution and expression in Huntington's disease: divergent mechanisms of action for similar movement disorders?
• Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington's disease
• Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's disease
• Refining the Language of Huntington's Disease Progression with the Huntington's Disease Integrated Staging System (HD-ISS)
• Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease
• Saccades, pupil response and blink abnormalities in Huntington's disease patients during free viewing
• Severe choreiform movement disorder following COVID-19
• Sex contribution to average age at onset of Huntington's disease depends on the number of (CAG)_n repeats
• Silymarin ameliorates motor function and averts neuroinflammation-induced cell death in the rat model of Huntington's disease
• Steroid-Responsive Involuntary Movements as a Remote Symptom of Febrile Infection-Related Epilepsy Syndrome
• Structural Mapping of Protein Aggregates in Live Cells Modeling Huntington's Disease
• Subacute hemichorea and asymmetrical basal ganglia abnormalities: An archetypal scenario for anti-CV2 encephalitis
• Subacute Onset of "Chorea" with Cervical Dystonia
• Supranuclear Palsy as an Initial Presentation of the Adult-Onset Niemann-Pick Type C
• Sydenham's chorea in a 16-year-old female from Bhutan: A case report
• Sydenham's Chorea in Children with Acute Rheumatic Fever: An Echocardiographic Survey of Pediatric Patients in Northwestern Iran
• Symptomatic Treatment of Extrapyramidal Hyperkinetic Movement Disorders
• Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging
• The phase coherence of the neurovascular unit is reduced in Huntington's disease
• The Role of Mitochondrial Copy Number in Neurodegenerative Diseases: Present Insights and Future Directions
• Towards Standardizing Nomenclature in Huntington's Disease Research
• Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol
• Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington's disease
• Unraveling Nonketotic Hyperglycemia Hemichorea-Hemiballismus Syndrome: A Case Report of Diagnosis and Management
• Unraveling the Molecular Complexity of N-Terminus Huntingtin Oligomers: Insights into Polymorphic Structures
• Vascular Leukoencephalopathy Associated Chorea Due to A Heterozygous Htra 1 Variant: Novel Presentation of Cadasil Type II
• Why genetic testing is important in patients with developmental disabilities-a unique case of progressive hypertonia and chorea: VARS2-related disorder